Tuesday, February 25, 2020

MHRA issues class 4 drug alert for Memantine 10 mg tablets

The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a class 4 pharmacy level caution in use for Memantine 10mg Film-Coated Tablets. Crescent Pharma Ltd...

BREAKING: Three more medicines banned from parallel export

Lopinavir + Ritonavir, Chloroquine phosphate and Azathioprine have all been added to the list of medicines carrying a parallel export ban. The restrictions will be in...

CPCF funding update: Pharmacy bodies express concern

Three leading pharma bodies have generally welcomed the recent update to the five-year Community Pharmacy Contractual Framework (CPCF) but are all concerned about some key...

Four new coronavirus cases in UK after cruise ship evacuees test positive

Four further patients in England have tested positive for COVID-19, bringing the total number of cases in the UK to 13. "The virus was passed...

Record two million people at risk of developing Type 2 diabetes

Around two million people in England are at risk of developing Type 2 diabetes, according to the latest NHS figures. The statistics, published today, show...

MHRA drug alert for Ibuprofen 400 mg tablets

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 drug alert for Ibuprofen 400 mg tablets. Crescent Pharma Ltd and Flamingo...

DHSC publishes second list of February price concessions

The Department of Health and Social Care (DHSC) on Friday published its second list of price concessions for February. The announcement, revealed by PSNC, follows...

Government announces new community pharmacy referral service to avoid hospital readmission

The government has announced that from July patients discharged from hospitals will be digitally referred to their local pharmacy teams for healthcare support and...

Macrolide taken during pregnancy may cause major birth defects: Study

The use of macrolide antibiotics during pregnancy is associated with an increased risk of major birth defects, according to a recent study. The study, published...

Boots launches ePrescription service for private patients

Boots UK is extending ePrescription service to private patients with the new Doctor Care Anywhere (DCA) digital prescription service. The service, which is being piloted...